Inhibition of mdr1 by G-quadruplex oligonucleotides and reversal of paclitaxel resistance in human ovarian cancer cells

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Tumor Biology

• Publication date

  2015-03-24

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1007/s13277-015-3333-2PMID 25801244
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MicroRNAs overexpressed in ovarian ALDH1-positive cells are associated with chemoresistance

  2013cited by this paper
• Oxidants, antioxidants and the current incurability of metastatic cancers

  2013cited by this paper
• Inhibition of Hec1 expression enhances the sensitivity of human ovarian cancer cells to paclitaxel

  2013cited by this paper
• Silencing of the STAT3 signaling pathway reverses the inherent and induced chemoresistance of human ovarian cancer cells.

  2013cited by this paper
• Enhancement of Cisplatin-Mediated Apoptosis in Ovarian Cancer Cells through Potentiating G2/M Arrest and p21 Upregulation by Combinatorial Epigallocatechin Gallate and Sulforaphane

  2013cited by this paper
• RNA G-quadruplexes: G-quadruplexes with "U" turns.

  2012cited by this paper
• Effect of G-Rich Oligonucleotides on the Proliferation of Leukemia Cells and Its Relationship with p53 Expression

  2011cited by this paper
• Revisiting the ABCs of multidrug resistance in cancer chemotherapy.

  2011cited by this paper
• Human telomeric G‐quadruplex: thermodynamic and kinetic studies of telomeric quadruplex stability

  2010cited by this paper
• Enhanced anti-HIV-1 activity of G-quadruplexes comprising locked nucleic acids and intercalating nucleic acids

  2010cited by this paper
• G‐quadruplex nucleic acids and human disease

  2010cited by this paper
• Direct assessment of P-glycoprotein efflux to determine tumor response to chemotherapy.

  2010cited by this paper
• Carbonylation of myosin heavy chains in rat heart during diabetes.

  2010cited by this paper
• Structure, location and interactions of G‐quadruplexes

  2010cited by this paper
• Screening and Improvement of an Anti-VEGF DNA Aptamer

  2010cited by this paper
• DNA G‐quadruplex: structure, function and human disease

  2010cited by this paper
• Mechanisms of chemotherapeutic drug resistance in cancer therapy--a quick review.

  2009cited by this paper
• Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer.

  2009cited by this paper
• G-quadruplex nucleic acids as therapeutic targets.

  2009cited by this paper
• Expression of multidrug resistance markers ABCB1 (MDR-1/P-gp) and ABCC1 (MRP-1) in renal cell carcinoma

  2009cited by this paper
• T40214/PEI complex: A potent therapeutics for prostate cancer that targets STAT3 signaling

  2008cited by this paper
• The nucleolin targeting aptamer AS1411 destabilizes Bcl-2 messenger RNA in human breast cancer cells.

  2008cited by this paper
• Four-stranded nucleic acids: structure, function and targeting of G-quadruplexes.

  2008cited by this paper
• Inhibition of Stat3 activation and tumor growth suppression of non-small cell lung cancer by G-quartet oligonucleotides.

  2007cited by this paper
• Geometric formalism for DNA quadruplex folding.

  2007cited by this paper
• Geometric formalism for DNA quadruplex folding.

  2007cited by this paper
• Cytotoxic G-rich oligodeoxynucleotides: putative protein targets and required sequence motif

  2007cited by this paper
• Avoiding bevacizumab related gastrointestinal toxicity for recurrent ovarian cancer by careful patient screening.

  2007cited by this paper
• Knock-down of P-glycoprotein reverses taxol resistance in ovarian cancer multicellular spheroids.

  2007cited by this paper
• AS1411 alters the localization of a complex containing protein arginine methyltransferase 5 and nucleolin.

  2007cited by this paper
• Anticancer drugs induce mdr1 gene expression in recurrent ovarian cancer

  2006cited by this paper
• Targeting signal transducer and activator of transcription 3 with G-quartet oligonucleotides: a potential novel therapy for head and neck cancer

  2006cited by this paper
• Interaction of G‐rich GT oligonucleotides with nuclear‐associated eEF1A is correlated with their antiproliferative effect in haematopoietic human cancer cell lines

  2006cited by this paper
• Multidrug resistance: retrospect and prospects in anti-cancer drug treatment.

  2006cited by this paper
• Editorial [Hot Topic: Anti-Cancer Drugs Executive Editor: Elke Bergmann-Leitner]

  2005cited by this paper
• G-Quartet Oligonucleotides

  2004cited by this paper
• Expression of multidrug resistance-1 protein inversely correlates with paclitaxel response and survival in ovarian cancer patients: a study in serial samples.

  2004cited by this paper
• G-quartet oligonucleotides: A new class of Stat3 inhibitors that suppresses growth of prostate and breast tumors through induction of apoptosis

  2004cited by this paper
• Paclitaxel resistance: molecular mechanisms and pharmacologic manipulation.

  2003cited by this paper
• A phase II study of the MDR inhibitor biricodar (INCEL, VX-710) and paclitaxel in women with advanced ovarian cancer refractory to paclitaxel therapy.

  2002cited by this paper
• Multidrug resistance gene-1 is a useful predictor of Paclitaxel-based chemotherapy for patients with ovarian cancer.

  2002cited by this paper
• Modulation of multidrug resistance in human ovarian cancer cell lines by inhibition of P-glycoprotein 170 and PKC isoenzymes with antisense oligonucleotides.

  2002cited by this paper
• Inhibition of DNA Replication and Induction of S Phase Cell Cycle Arrest by G-rich Oligonucleotides*

  2001cited by this paper
• Developing G-quartet oligonucleotides as novel anti-HIV agents: focus on anti-HIV drug design

  2000cited by this paper
• Multidrug resistance transporters and modulation

  2000cited by this paper
• Structure-Activity of Tetrad-forming Oligonucleotides as a Potent Anti-HIV Therapeutic Drug*

  1998cited by this paper
• Paclitaxel plus carboplatin in advanced non-small-cell lung cancer: a phase II trial.

  1996cited by this paper
• Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

  1996cited by this paper
• Multidrug resistance in the laboratory and clinic.

  1994cited by this paper
• Cellular and biochemical characterization of thioxanthenes for reversal of multidrug resistance in human and murine cell lines.

  1990cited by this paper
• Taxol: Mechanisms of Action and Resistance a

  1986cited by this paper

• Screening a living biobank identifies cabazitaxel as a strategy to combat acquired taxol resistance in high-grade serous ovarian cancer

  2025cites this paper
• In vitro models to evaluate multidrug resistance in cancer cells: Biochemical and morphological techniques and pharmacological strategies

  2024cites this paper
• Activation of the PERK/eIF2α axis is a pivotal prerequisite of taxanes to cancer cell apoptosis and renders synergism to overcome paclitaxel resistance in breast cancer cells

  2024cites this paper
• Nanoparticle-Based Combination Therapy for Ovarian Cancer.

  2023cites this paper
• Cancer multidrug-resistance reversal by ABCB1 inhibition: A recent update.

  2022cites this paper
• Research Progress and Prospects of Autophagy in the Mechanism of Multidrug Resistance in Tumors

  2022cites this paper
• Differential expression of ABCB1, ABCG2, and KLF4 as putative indicators for paclitaxel resistance in human epithelial type 2 cells

  2021cites this paper
• The role of a drug-loaded poly (lactic co-glycolic acid) (PLGA) copolymer stent in the treatment of ovarian cancer

  2020cites this paper
• Search for ABCB1 Modulators Among 2-Amine-5-Arylideneimidazolones as a New Perspective to Overcome Cancer Multidrug Resistance

  2020cites this paper
• A Compressive Review about Taxol®: History and Future Challenges

  2020cites this paper
• The ABCB1 3435C > T polymorphism influences docetaxel transportation in ovarian cancer

  2019cites this paper
• The use of nanotechnology for treatment of multidrug resistant ovarian cancer cells

  2019cites this paper
• https://researchopenworld.com/the-impact-of-p-glycoprotein-and-midkine-on-paclitaxel-cisplatin-chemoresistance-in-ovarian-cancer/#

  2018influential citation
• Emerging Therapeutics to Overcome Chemoresistance in Epithelial Ovarian Cancer: A Mini-Review

  2017cites this paper
• Myricetin induces apoptosis and enhances chemosensitivity in ovarian cancer cells.

  2017cites this paper
• Novel mechanisms and approaches to overcome multidrug resistance in the treatment of ovarian cancer.

  2016cites this paper
• Quantitative evaluation of ABC transporter-mediated drug resistance based on the determination of the anticancer activity of camptothecin against breast cancer stem cells using TIRF.

  2016cites this paper
• Different Facets of Copy Number Changes: Permanent, Transient, and Adaptive

  2016cites this paper
• Cross-reacting material 197 reverses the resistance to paclitaxel in paclitaxel-resistant human ovarian cancer

  2016cites this paper
• DUSP1 induces paclitaxel resistance through the regulation of p-glycoprotein expression in human ovarian cancer cells.

  2016cites this paper
• The role of ABC transporters in ovarian cancer progression and chemoresistance.

  2015cites this paper